Diagnosis and management of cryptococcal disease in resource-limited settings

被引：6
作者：
Vanselow M. [1 ]
Brandt M.E. [1 ]
Park B.J. [1 ]
机构：
[1] Mycotic Diseases Branch, Centers for Disease Control and Prevention, MS C-09, Atlanta, GA 30333
来源：
Current Fungal Infection Reports | 2012年 / 6卷 / 1期
关键词：
Amphotericin; Cryptococcal antigen; Cryptococcal meningitis; Cryptococcosis; Cryptococcus; Diagnosis; Fluconazole; HIV/AIDS; Lateral flow assay; Latex agglutination; Management; Resource-limited settings;
D O I：
10.1007/s12281-011-0082-6
中图分类号：
学科分类号：
摘要：
Cryptococcal meningitis is one of the most important fungal infections in the developing world, where deaths related to this disease are numerous. In resource-limited settings, mortality is high in large part because of difficulties in the diagnosis and management of this infection. This paper outlines many of the realities in many resource-limited settings, and describes priorities for public health action and research. © 2012 Springer Science+Business Media, LLC.
引用
收藏
页码：35 / 40
页数：5
相关论文
共 39 条
[31]  
Urdea M., Penny L.A., Et al., Requirements for high impact diagnostics in the developing world, Nature., 444, SUPPL. 1, pp. 73-79, (2006)
[32]  
Mock C., Nguyen S., Quansah R., Arreola-Risa C., Viradia R., Joshipura M., Evaluation of trauma care capabilities in four countries using the WHO-IATSIC Guidelines for Essential Trauma Care, World Journal of Surgery, 30, 6, pp. 946-956, (2006)
[33]  
Grimes C.E., Bowman K.G., Et al., Systematic review of barriers to surgical care in low-income and middle-income countries, World J Surg., 35, 5, pp. 941-950, (2011)
[34]  
Jackson A., Hosseinipour M.C., Management of cryptococcal meningitis in sub-Saharan Africa, Curr HIV/AIDS Rep., 7, 3, pp. 134-142, (2010)
[35]  
Liechty C.A., Solberg P., Were W., Ekwaru J.P., Ransom R.L., Weidle P.J., Downing R., Coutinho A., Mermin J., Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda, Tropical Medicine and International Health, 12, 8, pp. 929-935, (2007)
[36]  
Micol R., Lortholary O., Sar B., Laureillard D., Ngeth C., Dousset J.-P., Chanroeun H., Ferradini L., Guerin P.J., Dromer F., Fontanet A., Prevalence, determinants of positivity, and clinical utility of cryptococcal antigenemia in Cambodian HIV-infected patients, Journal of Acquired Immune Deficiency Syndromes, 45, 5, pp. 555-559, (2007)
[37]  
Jarvis J.N., Lawn S.D., Et al., Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa, Clin Infect Dis., 48, 7, pp. 856-862, (2009)
[38]  
Pongsai P., Atamasirikul K., Et al., The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts, J Infect., 60, 6, pp. 474-477, (2010)
[39]  
Micol R., Tajahmady A., Et al., Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia, PLoS One., 5, 11, (2010)
1234